Time for treating bone fracture using rhBMP-2: a randomised placebo controlled mouse fracture trial.

Abstract

Although the mechanisms of osteoinduction by bone morphogenic proteins (BMPs) are increasingly understood, the most appropriate time to administer BMPs exogenously is yet to be clarified. The purpose of this study was to investigate when BMP may be administered to a fracture arena to maximise the enhancement of healing. Forty mice with externally fixed left… (More)

Topics

5 Figures and Tables

Cite this paper

@article{Murnaghan2005TimeFT, title={Time for treating bone fracture using rhBMP-2: a randomised placebo controlled mouse fracture trial.}, author={Mark Murnaghan and Lisa McIlmurray and Moses T Mushipe and Gang Li}, journal={Journal of orthopaedic research : official publication of the Orthopaedic Research Society}, year={2005}, volume={23 3}, pages={625-31} }